| abstract |
The present application relates to variants of anti-IL-17A / F antibodies, in particular glycosylation variants, charge variants, acid variants, HMWS variants, reduction-resistant cross-linking variants, and anti-IL-17A / F antibodies and their It relates to compositions comprising the variant (s), methods of making the compositions, methods of characterization, and methods of use. [Selection figure] None |